title: Aspirin resistance in ischaemic heart disease.
abstract: BACKGROUND
  In spite of the usage of acetylsalicylic acid (aspirin) in the secondary prevention of ischaemic heart disease (IHD), new thrombo-embolic events occur in more than half of patients. Aspirin resistance may be partially responsible for this phenomenon.
  
  
  OBJECTIVE
  To assess the prevalence of aspirin resistance in patients with IHD and to correlate this phenomenon with the progression of atherosclerosis, concomitant diseases and other medication.
  
  
  METHODS
  The study group consisted of 205 patients (mean age 65.8 years, 95 females) with stable angina, recent coronary angiography and positive result of non-invasive stress tests, treated with 75 mg of aspirin for at least one week. Platelet aggregation was measured using the optical aggregation method. Aspirin resistance was defined as a mean collagen and ATP-induced platelet aggregation >70%.
  
  
  RESULTS
  Aspirin resistance was found in 41 (20%) patients and was significantly associated with previous coronary artery bypass grafting (CABG) (p<0.01) and three-vessel disease (p<0.05). Previous CABG was the only independent risk factor for the presence of aspirin resistance (OR 5.6; 95% CI 2.0-15.4; p<0.01).
  
  
  CONCLUSIONS
  Aspirin resistance is present in 20% of patients with stable angina. Previous CABG is an independent risk factor of this phenomenon.
authors.affiliation: Department of Cardiology, Medical Academy, Wrocław, Poland.
authors.forename: Wiktor
authors.initials: W
authors.lastname: Kuliczkowski
authors.forename: Bogumił
authors.initials: B
authors.lastname: Halawa
authors.forename: Bozena
authors.initials: B
authors.lastname: Korolko
authors.forename: Walentyna
authors.initials: W
authors.lastname: Mazurek
mesh_terms: D000368:Aged; D001241:Aspirin / Q000494:pharmacology*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D010979:Platelet Function Tests; D015995:Prevalence; D012307:Risk Factors
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin